4.4 Article

The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults

期刊

BIPOLAR DISORDERS
卷 12, 期 8, 页码 851-858

出版社

WILEY-BLACKWELL PUBLISHING, INC
DOI: 10.1111/j.1399-5618.2010.00877.x

关键词

aged; bipolar disorder; cognition

资金

  1. Public Health Service [K23 MH 073772, U01 MH68846, U01 MH70948, U01 MH068848, U01 MH68847, U01 MH74511, U01 MH68844, U01 MH74091]
  2. GlaxoSmithKline
  3. National Institute of Health
  4. Canadian Institutes for Health Research
  5. AstraZeneca
  6. Bristol-Myers Squibb
  7. Corcept
  8. Forest
  9. Janssen
  10. Pfizer
  11. Wyeth
  12. Cyberonics
  13. Stanley Foundation
  14. National Institute of Mental Health
  15. Suicide Prevention Internationals
  16. Mental Illness Research, Education and Clinical Center
  17. Cephalon
  18. American Foundation for Suicide Prevention
  19. NARSAD
  20. Evotec
  21. Roche
  22. Eli Lilly Co.
  23. Elan
  24. Novartis
  25. Sanofi
  26. Eisai

向作者/读者索取更多资源

Objectives: We describe the cognitive function of older adults presenting with bipolar disorder (BD) and mania and examine whether longer lifetime duration of BD is associated with greater cognitive dysfunction. We also examine whether there are negative, synergistic effects between lifetime duration of BD and vascular disease burden on cognition. Methods: A total of 87 nondemented individuals with bipolar I disorder, age 60 years and older, experiencing manic, hypomanic, or mixed episodes, were assessed with the Dementia Rating Scale (DRS) and the Framingham Stroke Risk Profile (FSRP) as a measure of vascular disease burden. Results: Subjects had a mean (SD) age of 68.7 (7.1) years and 13.6 (3.1) years of education; 50.6% (n = 44) were females, 89.7% (n = 78) were white, and 10.3% (n = 9) were black. They presented with overall and domain-specific cognitive impairment in memory, visuospatial ability, and executive function compared to age-adjusted norms. Lifetime duration of BD was not related to DRS total score, any other subscale scores, or vascular disease burden. FSRP scores were related to the DRS memory subscale scores, but not total scores or any other domain scores. A negative interactive effect between lifetime duration of BD and FSRP was only observed with the DRS construction subscale. Conclusions: In this study, lifetime duration of BD had no significant relationship with overall cognitive function in older nondemented adults. Greater vascular disease burden was associated with worse memory function. There was no synergistic relationship between lifetime duration of BD and vascular disease burden on overall cognition function. Addressing vascular disease, especially early in the course of BD, may mitigate cognitive impairment in older age.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据